Systemic Juvenile Idiopathic Arthritis Sjia clinical trials

Explore recruiting systemic juvenile idiopathic arthritis sjia clinical trials.

Recruiting systemic juvenile idiopathic arthritis sjia studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Systemic Juvenile Idiopathic Arthritis Sjia trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

I4V-MC-JAHU: Open-Label, Randomized Study with a Tocilizumab Reference Arm to Evaluate Safety, Efficacy and Pharmacokinetics of Baricitinib in Children from 1 to Less Than 18 Years of Age with Systemic Juvenile Idiopathic Arthritis

Belgium, Poland, Czechia, France, Austria, Italy +1 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

An Open-label, Sequential, Ascending, Repeated Dose-finding Study of Sarilumab, Administered with Subcutaneous (SC) Injection, in Children and Adolescents, Aged 1 to 17 Years, with Systemic Juvenile Idiopathic Arthritis (sJIA), Followed by an Extension Phase. Name: SKYPS

Ireland, Germany, Finland, Italy, Spain, Bulgaria +5 more

Therapeutic exploratory (Phase II) EU CTIS Study details

A Two-cohort, Open-label, Single-arm, Multicenter Study to Evaluate Efficacy, Safety and Tolerability, Pharmacokinetics and Pharmacodynamics of Emapalumab in Children and Adults with Macrophage Activation Syndrome (MAS) in Still's Disease (Including Systemic Juvenile Idiopathic Arthitis and Adult Onset Still's Disease) or with MAS in Systemic Lupus Erythematosus

Italy, Czechia, Netherlands

Phase II and Phase III (Integrated) EU CTIS Study details

Systemic Juvenile Idiopathic Arthritis Sjia trials by city

Systemic Juvenile Idiopathic Arthritis Sjia in Toronto Systemic Juvenile Idiopathic Arthritis Sjia in Vancouver Systemic Juvenile Idiopathic Arthritis Sjia in Montreal Systemic Juvenile Idiopathic Arthritis Sjia in Calgary Systemic Juvenile Idiopathic Arthritis Sjia in Edmonton Systemic Juvenile Idiopathic Arthritis Sjia in Ottawa Systemic Juvenile Idiopathic Arthritis Sjia in Winnipeg Systemic Juvenile Idiopathic Arthritis Sjia in Quebec City Systemic Juvenile Idiopathic Arthritis Sjia in Hamilton Systemic Juvenile Idiopathic Arthritis Sjia in Kitchener Systemic Juvenile Idiopathic Arthritis Sjia in London Systemic Juvenile Idiopathic Arthritis Sjia in Halifax Systemic Juvenile Idiopathic Arthritis Sjia in New York Systemic Juvenile Idiopathic Arthritis Sjia in Los Angeles Systemic Juvenile Idiopathic Arthritis Sjia in Chicago Systemic Juvenile Idiopathic Arthritis Sjia in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease